Table 2 shows demographic and clinical characteristics. Fig. 2 shows an eligibility summary for our clinical trial at a Flow Chart for Randomized Controlled Trials [25]. The main sites of pain pointed by women were suprapubic (22%), sacral (9%) and in both regions in association in 69% of them.